These measures will be conducive to more accurate screening of promising therapeutic targets for ALD, form a wider range of potential TCMs and NPs, and establish a deeper target identification system between these drug candidates and ALD-specific targets, which will provide an important reference and novel direction for research on drugs targeting gut microbiota during ALD therapy
T2D patients with and without established CVD were enrolled
Yet these findings are specific to clinical heart failure populations and involve L-carnitine, not ALCAR
doi: 10.3389/fimmu.2026.1650527 Received 18 January 2026 Revised 26 January 2026 Accepted 31 January 2026 Published 17 February 2026 Volume 17 - 2026 Edited by Fahmida Alam, Independent University, Bangladesh Reviewed by Xuefang Cao, University of Maryland, United States Perry Ayn Mayson Maza, Baylor College of Medicine, United States Dingchuan Peng, Capital Medical University, China Updates Copyright 2026 Liao, Wu, Gao, Xie, Li, Wang, Wang, Gao, Li and Gao
About one third of diabetic patients suffer from painful neuropathy [13]
Retrieved from Office of the Assistant Secretary for Planning and Evaluation (ASPE)